Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay

Muscle and Nerve

Volumn 20, Issue 7, 1997, Pages 800-808

  Gotti, C ^a   Balestra, B ^a   Mantegazza, R ^b   Tzartos, S ^c   Moretti, M ^a   Clementi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Antibodies; Enzyme linked immunosorbent assay; Immunoassay; Myasthenia gravis; Nicotinic acetylcholine receptor

Indexed keywords

ALPHA BUNGAROTOXIN; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ADULT; ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; REPRODUCIBILITY;

ACETYLCHOLINESTERASE; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BINDING SITES, ANTIBODY; BUNGAROTOXINS; ENZYMES, IMMOBILIZED; EPITOPES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYASTHENIA GRAVIS; POLYSTYRENES; PRECIPITIN TESTS;

EID: 0030961662     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B     Document Type: Article

References (13)

1. Besinger UA, Toyka K, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A: Long-term correlation of binding and blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1982;33:1316-1321.
2. Clementi F, Sher E: Antibody induced internalization of acetylcholine nicotinic receptor: kinetics, mechanism and selectivity. Eur Cell Biol 1985;37:220-228.
3. Drachman DB, Adams RN, Josifek LF: Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-775.
4. Drachman DB, DeSilva S, Ramsay D, Pestronk A: "Seronegative" myasthenia gravis: a humorally mediated variant of myasthenia gravis [abstract]. Neurology 1987;37(suppl 1):214.
5. Drachman D: Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
6. Gotti C, Conti-Tronconi BM, Raftery M: Mammalian muscle acetylcholine receptor: purification and characterization. Biochemistry 1982;21:3148-3154.
7. Gotti C, Mantegazza R, Clementi F: New antigen for antibody detection in myasthenia gravis. Neurology 1984;34:374-377.
8. Howard F, Lennon V, Finley J, Matsumoto J, Elveback L: Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann NY Acad Sci 1987;505:526-538.
9. Lefvert A, Bergstrom K, Matell G: Determination of acetylcholine receptor antibody in myasthenia gravis. J. Neurosurg Psychiatry 1978;41:394-403.
10. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD: Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-1059.
11. Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F: Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neural 1988;235:449-453.
12. Mossam S, Vincent A, Newson-Davis J: Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1986;i:116-119.
13. Oosterhuis H, Limburg PC, Hummel-Tappel E: Anti-acetylcholine receptor antibody in myasthenia gravis: II. Clinical and serological follow-up of individual patients. J Neural Sci 1983;58:371-385.